Literature DB >> 2879599

Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis.

P J Prouse, D Shawe, J M Gumpel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2879599      PMCID： PMC1342172          DOI： 10.1136/bmj.293.6559.1407

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  N Engl J Med       Date:  1973-09-06       Impact factor: 91.245

2.  Does sulphasalazine cause folate deficiency in rheumatoid arthritis?

Authors:  K A Grindulis; B McConkey
Journal:  Scand J Rheumatol       Date:  1985       Impact factor: 3.641

3.  Folate status in patients receiving maintenance doses of sulfasalazine.

Authors:  G F Longstreth; R Green
Journal:  Arch Intern Med       Date:  1983-05

4.  Sulphasalazine in rheumatoid arthritis.

Authors:  B McConkey; R S Amos; S Durham; P J Forster; S Hubball; L Walsh
Journal:  Br Med J       Date:  1980-02-16
  4 in total
  2 in total

Review 1.  Juvenile rheumatoid arthritis: therapeutic perspectives.

Authors:  Ian C Chikanza
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.

Authors:  M Farr; L Waterhouse; A E Johnson; G D Kitas; R W Jubb; P A Bacon
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.